177
Views
13
CrossRef citations to date
0
Altmetric
Articles

QSAR model for prediction of the therapeutic potency of N-benzylpiperidine derivatives as AChE inhibitors

, &
Pages 471-489 | Received 15 Feb 2017, Accepted 14 May 2017, Published online: 14 Jun 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

J. Devillers, V. Sartor, J.P. Doucet, A. Doucet-Panaye & H. Devillers. (2022) In silico prediction of mosquito repellents for clothing application. SAR and QSAR in Environmental Research 33:4, pages 239-257.
Read now
S. Bitam, M. Hamadache & H. Salah. (2020) 2D QSAR studies on a series of (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-1,3-oxazolidin-2-one as CETP inhibitors. SAR and QSAR in Environmental Research 31:6, pages 423-438.
Read now
M. Saxena, S. Nandi & A.K. Saxena. (2019) QSAR and molecular docking studies of lethal factor protease inhibitors against Bacillus anthracis. SAR and QSAR in Environmental Research 30:10, pages 715-731.
Read now
S. Bitam, M. Hamadache & S. Hanini. (2018) Prediction of therapeutic potency of tacrine derivatives as BuChE inhibitors from quantitative structure–activity relationship modelling. SAR and QSAR in Environmental Research 29:3, pages 213-230.
Read now

Articles from other publishers (9)

Affaf Khaouane, Samira Ferhat & Salah Hanini. (2023) A Quantitative Structure-Activity Relationship for Human Plasma Protein Binding: Prediction, Validation and Applicability Domain. Advanced Pharmaceutical Bulletin 13:4, pages 784-791.
Crossref
Le-Quang Bao, Daniel Baecker, Do Thi Mai Dung, Nguyen Phuong Nhung, Nguyen Thi Thuan, Phuong Linh Nguyen, Phan Thi Phuong Dung, Tran Thi Lan Huong, Bakhtiyor Rasulev, Gerardo M. Casanola-Martin, Nguyen-Hai Nam & Hai Pham-The. (2023) Development of Activity Rules and Chemical Fragment Design for In Silico Discovery of AChE and BACE1 Dual Inhibitors against Alzheimer’s Disease. Molecules 28:8, pages 3588.
Crossref
Mihajlo J. Krunić, Jelena Z. Penjišević, Relja V. Suručić, Sandra Šegan, Slađana V. Kostić-Rajačić & Ivana I. Jevtić. (2023) Structure-activity and binding orientations analysis of potent, newly synthesized, acetylcholinesterase inhibitors. Journal of Molecular Structure 1276, pages 134809.
Crossref
Mohsen Nekoeinia & Saeed Yousefinejad. (2021) QSAR analysis of the acetylcholinesterase inhibitory activity of some tertiary amine derivatives of cinnamic acid. Structural Chemistry 32:3, pages 1123-1132.
Crossref
Anil K. Saxena & Muneer Alam. (2020) ATP Synthase Inhibitors as Anti-tubercular Agents: QSAR Studies in Novel Substituted Quinolines. Current Topics in Medicinal Chemistry 20:29, pages 2723-2734.
Crossref
Kiran Bagri, Ashwani Kumar, Manisha & Parvin Kumar. (2020) Computational Studies on Acetylcholinesterase Inhibitors: From Biochemistry to Chemistry. Mini-Reviews in Medicinal Chemistry 20:14, pages 1403-1435.
Crossref
Tiziana Ginex, Javier Vazquez, Enric Gilbert, Enric Herrero & Francisco J Luque. (2019) Lipophilicity in drug design: an overview of lipophilicity descriptors in 3D-QSAR studies. Future Medicinal Chemistry 11:10, pages 1177-1193.
Crossref
Mabrouk Hamadache, Othmane Benkortbi, Salah Hanini & Abdeltif Amrane. (2017) QSAR modeling in ecotoxicological risk assessment: application to the prediction of acute contact toxicity of pesticides on bees (Apis mellifera L.). Environmental Science and Pollution Research 25:1, pages 896-907.
Crossref
Amit Kumar Halder, Ana S. Moura & M. Natália D. S. Cordeiro. 2019. Multi-Target Drug Design Using Chem-Bioinformatic Approaches. Multi-Target Drug Design Using Chem-Bioinformatic Approaches 155 186 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.